.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 4,801,587

« Back to Dashboard

Claims for Patent: 4,801,587

Title: Impotence ointment
Abstract:An ointment for relieving impotence. The ointment generally consists of a primary agent, a carrier, and a base, and is applied directly to the penis. The primary agent is a vasodilator selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine. The carrier is used to assist absorption of the primary agent through the skin around the penis. When the primary agent enters the corpora cavernosa within the penis, it causes dilation of the corpora, resulting in an erection.
Inventor(s): Voss; Gene (San Antonio, TX), Eichler; Allen C. (San Antonio, TX)
Assignee:
Application Number:07/020,544
Patent Claims: 1. A method of relieving impotence comprising the single step of applying an ointment to the skin around the penis, said ointment comprising:

a primary agent, being a vasodilator, selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine or phentolamine, said primary agent being present in said ointment in an amount between one and five percent by weight;

dimethyl sulfoxide for assisting absorption of said primary agent through said skin; and

a base.

2. The method of claim 1 wherein said ointment is applied to the glans portion of the penis.

3. A method of relieving impotence comprising the steps of:

applying a first ointment to the skin around the penis, said first ointment containing only a carrier for assisting absorption of a primary agent through said skin;

removing said first ointment from said skin after a short period of time; and

applying a second ointment to said skin said second ointment containing said primary agent, wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine, and said primary agent is present in said second ointment in an amount between one and five percent by weight.

4. The method of claim 3 wherein said carrier is dimethoxy sulfoxide.

5. The method of claim 3 wherein said first and second ointments are applied to the glans portion of said penis.

6. A method of relieving impotence comprising the steps of:

placing a catheter within the urethra of the penis, said catheter being in fluid communication with a tube, said tube containing an ointment, said ointment comprising a primary agent and a base, wherein said primary agent is a vasodilator and is present in an amount of between one and five percent by weight; and

squeezing said tube thereby extruding said ointment into said catheter and into said urethra.

7. The method of claim 6 wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine.

8. The method of claim 6 wherein said ointment further comprises a carrier for assisting absorption of said primary agent through the wall of said urethra.

9. The method of claim 8 wherein said carrier is dimethoxy sulfoxide.

10. A method of relieving impotence comprising the steps of:

surgically removing a portion of the fibrous sheath surrounding the corpora cavernosa within the penis; and

applying an ointment to the skin around said penis, said ointment comprising a primary agent, being a vasodilator, and a base, said primary agent being present in an amount of between one and five percent by weight.

11. The method of claim 10 wherein said primary agent is selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine.

12. The method of claim 10 wherein said ointment further comprises a carrier for missing absorption of said primary agent through the wall of said urethra.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc